Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia von Byrd, John C, Harrington, Bonnie, O’Brien, Susan, Jones, Jeffrey A, Schuh, Anna, Devereux, Steve, Chaves, Jorge, Wierda, William G, Awan, Farrukh T, Brown, Jennifer R, Hillmen, Peter, Stephens, Deborah M, Ghia, Paolo, Barrientos, Jacqueline C, Pagel, John M, Woyach, Jennifer, Johnson, Dave, Huang, Jane, Wang, Xiaolin, Kaptein, Allard, Lannutti, Brian J, Covey, Todd, Fardis, Maria, McGreivy, Jesse, Hamdy, Ahmed, Rothbaum, Wayne, Izumi, Raquel, Diacovo, Thomas G, Johnson, Amy J, Furman, Richard R

Volltext

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma von Sarnaik, Amod A., Hamid, Omid, Khushalani, Nikhil, Lewis, Karl D., Medina, Theresa, Kluger, Harriet M., Thomas, Sajeve S., Domingo-Musibay, Evidio, Pavlick, Anna C., Whitman, Eric D., Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D., Olah, Judit, Lutzky, Jose, Weber, Jeffrey S., Larkin, James M. G., Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Finckenstein, Friedrich Graf, Fardis, Maria, Kirkwood, John M., Chesney, Jason A.

Volltext

Synthesis of 1-amino-2-vinylcyclopropane-1-phosphinates. Conversion of a phosphonate to phosphinates von Pyun, Hyung-Jung, Clarke, Michael O., Cho, Aesop, Casarez, Anthony, Ji, Mingzhe, Fardis, Maria, Pastor, Richard, Sheng, X. Christopher, Kim, Choung U.

Volltext

Effect of substitution on novel tricyclic HIV-1 integrase inhibitors von Fardis, Maria, Jin, Haolun, Jabri, Salman, Cai, Ruby Z., Mish, Michael, Tsiang, Manuel, Kim, Choung U.

Volltext

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma von Wilson, Wyndham H, Young, Ryan M, Schmitz, Roland, Yang, Yandan, Pittaluga, Stefania, Wright, George, Lih, Chih-Jian, Williams, P Mickey, Shaffer, Arthur L, Gerecitano, John, de Vos, Sven, Goy, Andre, Kenkre, Vaishalee P, Barr, Paul M, Blum, Kristie A, Shustov, Andrei, Advani, Ranjana, Fowler, Nathan H, Vose, Julie M, Elstrom, Rebecca L, Habermann, Thomas M, Barrientos, Jacqueline C, McGreivy, Jesse, Fardis, Maria, Chang, Betty Y, Clow, Fong, Munneke, Brian, Moussa, Davina, Beaupre, Darrin M, Staudt, Louis M

Volltext

1698316 Phase 1 Healthy Volunteer Data Supports Phase 2 Study of LASN01 in Thyroid Eye Disease (TED) – Actively Enrolling von Arora, Puneet, Tanamly, Susie, Takamura, Toshimi, Chung, Young, Jun, Toni, Swaney, Jamie, King, David, Fardis, Maria

Volltext

Abstract LB-110: Anti-OX40 agonistic antibody enhances ex vivo CD8+ TIL expansion with increased T-cell effector function von Ritthipichai, Krit, Machin, Marcus, Fardis, Maria, Chartier, Cecile

Volltext

Abstract CT246: A phase 2 multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN-145) cell therapy in patients with metastatic non-small cell lung cancer (mNSCLC) von Massarelli, Erminia, Goldberg, Zelanna, Cacovean, Alex, Yadav, Bhagyashree, Chen, Guang, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Sukari, Ammar

Volltext

Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Tri... von Brown, J. Jennifer R., MD, PhD, Byrd, John C., MD, O’Brien, Susan, MD, Barrientos, Jacqueline C., MD, Kay, Neil E., MD, Reddy, Nishitha M., MBBS, MD, Coutre, Steven, MD, Tam, Constantine S., MBBS, MD, Mulligan, Stephen, MBBS, PhD, FRACP, FRCPA, Jaeger, Ulrich, MD, Devereux, Stephen, PhD, FRCP, FRCPath, Barr, Paul M., MD, Furman, Richard, MD, Kipps, Thomas, MD, PhD, Cymbalista, Florence, MD, PhD, Fardis, Maria, PhD, MBA, McGreivy, Jesse, MD, Clow, Fong, DSc, James, Danelle F., MD, MAS, Hillmen, Peter, MD, PhD, FRCP, FRCPath

Volltext

Abstract CT244: A Phase 1/2 study evaluating the safety and efficacy of IOV-2001 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lym... von Long, Meixiao, Woyach, Jennifer, Pinilla-Ibarz, Javier, Stephens, Deborah M., Cacovean, Alex, Fiaz, Rana, Goldberg, Zelanna, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Byrd, John C.

Volltext

Abstract A05: Expansion of tumor-infiltrating lymphocytes (TIL) using Iovance's Gen 2 process from advanced bladder cancer for adoptive immunotherapy von LI, Qiang J., Guru, Khurshid, Lugade, Amit, Brese, Elizabeth, Odunsi, Kunle, Veerapathran, Anand, Onimus, Kenneth, Wells, Adrian, Chartier, Cecile, Natarajan, Arvind, Fardis, Maria, Chatta, Gurkamal

Volltext

Abstract CT235: A Phase 2, multicenter study of autologous tumor infiltrating lymphocytes (TIL, LN 144/LN-145/LN-145-S1) in patients with solid tumors von Gettinger, Scott, Kluger, Harriet, Schoenfeld, Adam, Betof-Warner, Allison, He, Kai, Sukari, Ammar, Doger de Speville Uribe, Bernard, Lee, Sylvia, Haefliger, Simon, Goldberg, Zelanna, Cacovean, Alex, Fiaz, Rana, Chen, Guang, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Jimeno, Antonio

Volltext

Safety and efficacy of lifileucel (LN-144), an autologous, tumor infiltrating lymphocyte cell therapy in combination with pembrolizumab for immune checkpoint inhibitor naïve patien... von Thomas, Sajeve Samuel, In, Gino Kim, Doger, Bernard, Haefliger, Simon, Martin-Liberal, Juan, Goldberg, Zelanna, Cacovean, Alex, Fiaz, Rana, Chen, Guang, Jagasia, Madan H., Graf Finckenstein, Friedrich, Fardis, Maria, Jimeno, Antonio

Volltext

Abstract 649: Emigrant pre-REP tumor infiltrating lymphocytes profoundly differ from remnant T-cells von Simpson-Abelson, Michelle R., Mosychuk, Christopher, Fardis, Maria, Lotze, Michael T.

Volltext

Abstract CT173: A phase II study to assess the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-145) alone and in combination with anti-PD-L1 inhibitor durvalum... von Lee, Sylvia, Villaflor, Viktoriya, Haigentz, Missack, Karyampudi, Kumar, Tanamly, Susie, Suzuki, Sam, Gorbatchevsky, Igor, Fardis, Maria, Villaruz, Liza

Volltext

A phase 2 study to assess the efficacy and safety of autologous tumor-infiltrating lymphocytes (TIL, LN-145) alone and in combination with anti-PD-L1 inhibitor durvalumab in patien... von Lee, Sylvia Mina, Haigentz, Missak, Villaruz, Liza Cosca, Gorbatchevsky, Igor, Suzuki, Sam, Tanamly, Susie, Samberg, Nancy Louise, Fardis, Maria

Volltext

Abstract CT008: Lifileucel (LN-144), a cryopreserved autologous tumor infiltrating lymphocyte (TIL) therapy in patients with advanced (unresectable or metastatic) melanoma: durable... von Chesney, Jason Alan, Larkin, James M., Kirkwood, John M., Weber, Jeffrey S., Khushalani, Nikhil I., Lewis, Karl, Medina, Theresa M., Kluger, Harriet M., Thomas, Sajeve S., Domingo-Musibay, Evidio, Oláh, Judit, Whitman, Eric D., Martin-Algarra, Salvador, Corrie, Philippa G., Lutzky, Jose, Hamid, Omid, Shi, Wen, Wu, Xiao, Jagasia, Madan, Finckenstein, Friedrich Graf, Fardis, Maria, Sarnaik, Amod A.

Volltext

Lifileucel (LN-144), a cryopreserved autologous tumor infiltrating lymphocyte (TIL) therapy in patients with advanced melanoma: Evaluation of impact of prior anti-PD-1 therapy von Larkin, James, Sarnaik, Amod, Chesney, Jason Alan, Khushalani, Nikhil I., Kirkwood, John M., Weber, Jeffrey S., Lewis, Karl D., Medina, Theresa Michelle, Kluger, Harriet M., Thomas, Sajeve Samuel, Domingo-Musibay, Evidio, Olah, Judit, Whitman, Eric D., Martin-Algarra, Salvador, Corrie, Philippa Gail, Lutzky, Jose, Shi, Wen, Wu, Renee Xiao, Fardis, Maria, Hamid, Omid

Volltext

Abstract CT170: A phase II, multicenter study to evaluate the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-145) for the treatment of patients with recurrent... von Leidner, Rom, Sukari, Ammar, Chung, Christine, Ohr, James, Haigentz, Missak, Cohen, Ezra, Brown, Robert, Suzuki, Sam, Gorbatchevsky, Igor, Fardis, Maria, Ferris, Robert L.

Volltext

A phase 2, multicenter study to evaluate the efficacy and safety of autologous tumor infiltrating lymphocytes (LN-145) for the treatment of patients with recurrent and/or metastati... von Leidner, Rom S., Sukari, Ammar, Chung, Christine H., Ohr, James, Haigentz, Missak, Cohen, Ezra E.W., Brown, Robert James, Suzuki, Samuel, Gorbatchevsky, Igor, Fardis, Maria, Ferris, Robert L.

Volltext